Christopher A. Ross

57.5k total citations · 13 hit papers
359 papers, 40.5k citations indexed

About

Christopher A. Ross is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Christopher A. Ross has authored 359 papers receiving a total of 40.5k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Cellular and Molecular Neuroscience, 231 papers in Molecular Biology and 124 papers in Neurology. Recurrent topics in Christopher A. Ross's work include Genetic Neurodegenerative Diseases (218 papers), Mitochondrial Function and Pathology (135 papers) and Neurological disorders and treatments (85 papers). Christopher A. Ross is often cited by papers focused on Genetic Neurodegenerative Diseases (218 papers), Mitochondrial Function and Pathology (135 papers) and Neurological disorders and treatments (85 papers). Christopher A. Ross collaborates with scholars based in United States, Canada and United Kingdom. Christopher A. Ross's co-authors include Michelle A. Poirier, Sarah J. Tabrizi, Russell L. Margolis, David A. Ruggiero, Donald J. Reis, Ted M. Dawson, Alan H. Sharp, Valina L. Dawson, Solomon H. Snyder and Wanli W. Smith and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher A. Ross

356 papers receiving 39.7k citations

Hit Papers

Protein aggregation and neurodegenerative dis... 1984 2026 1998 2012 2004 1997 2010 2015 2005 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Protein aggregation and neurodegenerative disease
    2004 2.7k citations Christopher A. Ross et al. profile →
  2. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
    1997 1.8k citations Christopher A. Ross et al. profile →
  3. Huntington's disease: from molecular pathogenesis to clinical treatment
    2010 1.2k citations Christopher A. Ross et al. profile →
  4. Huntington disease
    2015 1.1k citations Michael R. Hayden, Christopher A. Ross et al. profile →
  5. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
    2005 945 citations Wanli W. Smith, Christopher A. Ross et al. Proceedings of the National Academy of Sciences profile →
  6. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity
    2001 880 citations Frederick C. Nucifora, Juan C. Troncoso et al. profile →
  7. Huntington disease: natural history, biomarkers and prospects for therapeutics
    2014 705 citations Christopher A. Ross, Jane S. Paulsen et al. profile →
  8. A huntingtin-associated protein enriched in brain with implications for pathology
    1995 512 citations Frederick C. Nucifora, Gabriele Schilling et al. profile →
  9. Neurobiology of Schizophrenia
    2006 508 citations Christopher A. Ross, Russell L. Margolis et al. profile →
  10. Kinase activity of mutant LRRK2 mediates neuronal toxicity
    2006 506 citations Wanli W. Smith, Zhong Pei et al. profile →
  11. Rostral ventrolateral medulla: Selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons
    1984 485 citations Christopher A. Ross et al. profile →
  12. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
    2020 330 citations Christopher A. Ross et al. profile →
  13. A biological classification of Huntington's disease: the Integrated Staging System
    2022 142 citations Christopher A. Ross et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. Ross United States 105 24.7k 23.0k 12.4k 5.4k 3.7k 359 40.5k
James F. Gusella United States 96 22.3k 0.9× 14.1k 0.6× 10.4k 0.8× 7.1k 1.3× 3.0k 0.8× 462 41.2k
Allan I. Levey United States 118 24.0k 1.0× 26.2k 1.1× 7.0k 0.6× 11.8k 2.2× 3.0k 0.8× 507 52.1k
David Sulzer United States 94 10.4k 0.4× 14.8k 0.6× 10.7k 0.9× 4.4k 0.8× 4.2k 1.1× 248 28.9k
Stuart A. Lipton United States 125 26.9k 1.1× 18.7k 0.8× 4.1k 0.3× 12.3k 2.3× 3.2k 0.9× 386 52.8k
Patrik Brundin Sweden 97 14.5k 0.6× 17.7k 0.8× 15.5k 1.3× 5.6k 1.0× 1.6k 0.4× 363 35.5k
Olle Lindvall Sweden 107 15.9k 0.6× 23.9k 1.0× 7.5k 0.6× 3.9k 0.7× 1.3k 0.3× 362 42.7k
Valina L. Dawson United States 126 26.9k 1.1× 15.8k 0.7× 18.4k 1.5× 12.9k 2.4× 4.9k 1.3× 380 56.5k
Isidró Ferrer Spain 101 20.4k 0.8× 11.4k 0.5× 8.3k 0.7× 12.8k 2.4× 3.2k 0.9× 910 42.1k
Ted M. Dawson United States 133 28.9k 1.2× 19.4k 0.8× 20.6k 1.7× 15.3k 2.8× 5.3k 1.4× 433 61.8k
Stephen G. Waxman United States 110 23.7k 1.0× 22.1k 1.0× 6.4k 0.5× 18.5k 3.4× 1.7k 0.4× 684 46.5k

Countries citing papers authored by Christopher A. Ross

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Ross more than expected).

Fields of papers citing papers by Christopher A. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Ross. The network helps show where Christopher A. Ross may publish in the future.

Co-authorship network of co-authors of Christopher A. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Ross. A scholar is included among the top collaborators of Christopher A. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Ross. Christopher A. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ratovitski, Tamara, et al.. (2023). Arginine methylation of RNA-binding proteins is impaired in Huntington’s disease. Human Molecular Genetics. 32(20). 3006–3025. 1 indexed citations
2.
Younès, Laurent, Xuan Bu, J. Tilak Ratnanather, et al.. (2023). Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington’s disease. NeuroImage Clinical. 39. 103493–103493. 1 indexed citations
3.
Feng, Hongxuan, Xin Hu, Xin Sun, et al.. (2021). A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity. Scientific Reports. 11(1). 6157–6157. 7 indexed citations
4.
Ayhan, Fatma, B. Pérez, Hannah K. Shorrock, et al.. (2018). SCA 8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF 3F. The EMBO Journal. 37(19). 47 indexed citations
5.
Dickey, Audrey S., Weiwei Fan, Nicolas Arbez, et al.. (2017). PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Science Translational Medicine. 9(419). 47 indexed citations
6.
Nucifora, Leslie G., Brian J. Lee, Sha Li, et al.. (2016). A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation. PubMed. 2(3). 133–144. 19 indexed citations
7.
Ratovitski, Tamara, Xiaofang Wang, Mali Jiang, et al.. (2012). Transgenic Mouse Model Expressing the Caspase 6 Fragment of Mutant Huntingtin. Journal of Neuroscience. 32(1). 183–193. 45 indexed citations
8.
Juopperi, Tarja, Jason Chiang, Huimei Yu, et al.. (2012). Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells. Molecular Brain. 5(1). 17–17. 184 indexed citations
9.
Reading, Sarah, Kenichi Oishi, Graham W. Redgrave, et al.. (2011). Diffuse Abnormality of Low to Moderately Organized White Matter in Schizophrenia. Brain Connectivity. 1(6). 511–519. 8 indexed citations
10.
11.
Liu, Zhong Wu, Ying Liang, Naoki Masuda, et al.. (2010). Synphilin-1 attenuates neuronal degeneration in the A53T  -synuclein transgenic mouse model. Human Molecular Genetics. 19(11). 2087–2098. 57 indexed citations
12.
Sawa, Akira, Eiichiro Nagata, Siobhan Sutcliffe, et al.. (2005). Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts. Neurobiology of Disease. 20(2). 267–274. 35 indexed citations
13.
Smith, Wanli W., Haibing Jiang, Zhong Pei, et al.. (2005). Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Human Molecular Genetics. 14(24). 3801–3811. 303 indexed citations
14.
Lim, Kah‐Leong, Katherine C. M. Chew, Jeanne M.M. Tan, et al.. (2005). Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation. Journal of Neuroscience. 25(8). 2002–2009. 454 indexed citations
15.
Schilling, Gabriele, et al.. (2004). Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Experimental Neurology. 187(1). 137–149. 67 indexed citations
16.
Holmes, Susan E., Melvin G. McInnis, Akira Sawa, et al.. (2003). Novel CAG/CTG repeat expansion mutations do not contribute to the genetic risk for most cases of bipolar disorder or schizophrenia. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 124B(1). 15–19. 7 indexed citations
17.
Nucifora, Frederick C., Lisa Ellerby, Cheryl L. Wellington, et al.. (2003). Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity. Journal of Biological Chemistry. 278(15). 13047–13055. 68 indexed citations
18.
Holbert, Sébastien, Adam Rosenblatt, Cheryl L. Wellington, et al.. (2001). The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proceedings of the National Academy of Sciences. 98(4). 1811–1816. 143 indexed citations
19.
Ross, Christopher A.. (1997). Genes with triplet repeats. The FASEB Journal. 11(9). 3 indexed citations
20.
Wagster, Molly V., John C. Hedreen, Carol E. Peyser, Susan E. Folstein, & Christopher A. Ross. (1994). Selective Loss of [3H]Kainic Acid and [3H]AMPA Binding in Layer VI of Frontal Cortex in Huntington's Disease. Experimental Neurology. 127(1). 70–75. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James F. Gusella Breakdown of academic impact, for papers by Allan I. Levey Breakdown of academic impact, for papers by David Sulzer Breakdown of academic impact, for papers by Stuart A. Lipton Breakdown of academic impact, for papers by Patrik Brundin Breakdown of academic impact, for papers by Olle Lindvall Breakdown of academic impact, for papers by Valina L. Dawson Breakdown of academic impact, for papers by Isidró Ferrer Breakdown of academic impact, for papers by Ted M. Dawson Breakdown of academic impact, for papers by Stephen G. Waxman
Rankless by CCL
2026